3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Melanoma
3
Lung Neoplasms
3
Colitis
3
Urogenital Neoplasms
2
Solid Carcinoma
2
Diarrhea
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Gastrointestinal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced Gastric Cancer
1
Interventions
Dexamethasone
5
Trimethoprim, Sulfamethoxazole Drug Combination
4
gamma-Globulins
3
Lenalidomide
3
Ciprofloxacin
3
Bortezomib
3
pomalidomide
2
fludarabine phosphate
2
fludarabine
2
elotuzumab
2
carfilzomib
2
Radiotherapy
2
Immunoglobulins, Intravenous
2
Cyclophosphamide
2
Amoxicillin-Potassium Clavulanate Combination
2
siltuximab
1
selinexor
1
nirogacestat
1
iberdomide
1
daratumumab
1
belantamab mafodotin
1
Positron-Emission Tomography
1
Melphalan
1
Interviews as Topic
1
Immunoglobulins
1
Focus Groups
1
Fecal Microbiota Transplantation
1
Clonal Hematopoiesis
1
Clavulanic Acid
1
Chromatin Immunoprecipitation Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Plasma Cell
×
Fecal Microbiota Transplantation
×
Clear all
NCT04935684
2023-03-01
TMF-Allo
University Hospital, Clermont-Ferrand
Phase 2
Recruiting
150 enrolled